| Basics |
|
CeriBell, Inc. Common Stock
|
| IPO Date: |
October 11, 2024 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$458.3M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.52 | 2.70%
|
| Avg Daily Range (30 D): |
$0.31 | 2.55%
|
| Avg Daily Range (90 D): |
$0.35 | 2.51%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.23M |
| Avg Daily Volume (30 D): |
.2M |
| Avg Daily Volume (90 D): |
.23M |
| Trade Size |
| Avg Trade Size (Sh.): |
59 |
| Avg Trade Size (Sh.) (30 D): |
50 |
| Avg Trade Size (Sh.) (90 D): |
52 |
| Institutional Trades |
| Total Inst.Trades: |
135 |
| Avg Inst. Trade: |
$1.74M |
| Avg Inst. Trade (30 D): |
$1.58M |
| Avg Inst. Trade (90 D): |
$1.81M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.97M |
| Avg Closing Trade (30 D): |
$3.57M |
| Avg Closing Trade (90 D): |
$2.29M |
| Avg Closing Volume: |
95.3K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
FY 2024 |
|
Basic EPS
|
$-.38
|
$-.36
|
$-3.39
|
|
Diluted EPS
|
$-.38
|
$-.36
|
$-3.39
|
|
Revenue
|
$ 21.2M
|
$ 20.49M
|
$ 65.44M
|
|
Gross Profit
|
$ 18.68M
|
$ 18.01M
|
$ 56.75M
|
|
Net Income / Loss
|
$ -13.64M
|
$ -12.78M
|
$ -40.46M
|
|
Operating Income / Loss
|
$ -14.95M
|
$ -14.21M
|
$ -39.71M
|
|
Cost of Revenue
|
$ 2.52M
|
$ 2.48M
|
$ 8.69M
|
|
Net Cash Flow
|
$ -113.22M
|
$ -41.01M
|
$ 159.88M
|
|
PE Ratio
|
|
|
|
|
|
|
